advertisement

---

Odani-Kawabata N 1

Showing records 1 to 1 | Display all abstracts from Odani-Kawabata N

80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Aihara M; Lu F; Kawata H; Iwata A; Liu K; Odani-Kawabata N; Shams NK
Journal of Glaucoma 2019; 28: 375-385

---